Body Weight Telemetry Is Useful to Reduce Interdialytic Weight Gain in Patients with End-Stage Renal Failure on Hemodialysis

被引:16
|
作者
Neumann, Claas L. [1 ]
Wagner, Fabian [1 ]
Menne, Jan [2 ]
Brockes, Christiane [3 ]
Schmidt-Weitmann, Sabine [3 ]
Rieken, Eike M. [1 ]
Schettler, Volker [1 ]
Hagenah, Gerrit C. [1 ]
Matzath, Stephan [5 ]
Zimmerli, Lukas [4 ]
Haller, Hermann [2 ]
Schulz, Egbert G. [1 ]
机构
[1] Ctr Nephrol Gottingen, D-37075 Gottingen, Germany
[2] Hannover Med Sch, Clin Nephrol, Hannover, Germany
[3] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[4] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland
[5] HELIOS Albert Schweitzer Clin Northeim, Med Clin 1, Northeim, Germany
关键词
telemedicine; telemetry; diagnostic techniques and procedures; patient compliance; hemodialysis; interdialytic weight gain; body weight; blood pressure; fluid intake; AMBULATORY BLOOD-PRESSURE; PULSE PRESSURE; CARDIOVASCULAR RISK; DIALYSIS PATIENTS; HEART-FAILURE; UNITED-STATES; MORTALITY; HYPERTENSION; DISEASE; SURVIVAL;
D O I
10.1089/tmj.2012.0188
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Lacking compliance with liquid intake restrictions is one of the major problems in patients on hemodialysis and causes an increased mortality. In 120 patients on hemodialysis with an average interdialytic weight gain (IWG) exceeding 1.5 kg on at least 2 days during the 4 weeks preceding the intervention, the effect of telemetric body weight measurement (TBWM) on IWG, ultrafiltration rate, and blood pressure was evaluated over a period of 3 months. Patients of the telemetric group (TG) were supplied with automatic scales, which transferred the weight via telemetry on a daily basis. In the case of IWG of more than 0.75 kg/24 h, a telephonic contact was made as required, and in the case of an IWG of more than 1.5 kg, telephonic contacting was obligatory along with the advice of a liquid intake restriction to 0.5 L/day until the next dialysis. The patients of the control group (CG) received standard treatment without telemetric monitoring. We examined specific data of the second interdialytic interval (IDI2) and the average within 1 week. The average difference of IWG between TG and CG was not significant before the start of the study but 0.2 kg (p = 0.027) (IDI2)/0.27kg (p = 0.001) (WP) at the end of the study, respectively. The average difference in the ultrafiltration rate within 1 week was 19.0 mL/h (p = 0.282) (IDI2)/8.2 mL/h (p = 0.409) before the start of the study but 28.4 mL/h (p = 0.122) (IDI2)/30.9 mL/h (p = 0.004) at the end of the study, respectively. Thus, TBWM is a feasible method for optimizing the IWG and reducing the ultrafiltration rate.
引用
收藏
页码:480 / 486
页数:7
相关论文
共 50 条
  • [41] INTERDIALYTIC WEIGHT-GAIN AND NUTRITIONAL PARAMETERS IN CHRONIC-HEMODIALYSIS PATIENTS
    SHERMAN, RA
    CODY, RP
    ROGERS, ME
    SOLANCHICK, JC
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (04) : 579 - 583
  • [42] Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients
    Knerr, K
    Füth, R
    Hemsen, P
    Mohné, W
    Heinig, A
    Kleophas, W
    Scherbaum, WA
    Martin, S
    CYTOKINE, 2005, 30 (03) : 132 - 138
  • [43] Stimulated sweating as a therapy to reduce interdialytic weight gain and improve potassium balance in chronic hemodialysis patients: A pilot study
    Pruijm, Menno
    El-Housseini, Youssef
    Mahfoudh, Hichem
    Jarraya, Faycal
    Hachicha, Jamil
    Teta, Daniel
    Burnier, Michel
    HEMODIALYSIS INTERNATIONAL, 2013, 17 (02) : 240 - 248
  • [44] Stimulated Sweating as a Therapy To Reduce Interdialytic Weight Gain and Improve Potassium Balance in Chronic Hemodialysis Patients: A Pilot Study
    Pruijm, M.
    El-Housseini, Y.
    Mahfoudh, H.
    Jarraya, F.
    Hachicha, J.
    Teta, D.
    Burnier, M.
    SWISS MEDICAL WEEKLY, 2012, 142 : 4S - 4S
  • [45] Prognosis of bedridden patients with end-stage renal failure after starting hemodialysis
    Sugaya K.
    Hokama A.
    Hayashi E.
    Naka H.
    Oda M.
    Nishijima S.
    Miyazato M.
    Hokama S.
    Ogawa Y.
    Clinical and Experimental Nephrology, 2007, 11 (2) : 147 - 150
  • [46] REMOVAL OF IMIPENEM AND CILASTATIN BY HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL-FAILURE
    KONISHI, K
    SUZUKI, H
    SARUTA, T
    HAYASHI, M
    DEGUCHI, N
    TAZAKI, H
    HISAKA, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) : 1616 - 1620
  • [47] Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients
    Piperi, C
    Kalofoutis, C
    Tzivras, M
    Troupis, T
    Skenderis, A
    Kalofoutis, A
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 265 (1-2) : 57 - 61
  • [48] The effect of hemodialysis on right ventricular functions in patients with end-stage renal failure
    Akkaya, Mehmet
    Erdogan, Ercan
    Sag, Saim
    Ari, Hasan
    Turker, Yasin
    Yilmaz, Mustafa
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2012, 12 (01): : 5 - 10
  • [49] VOLUNTARY WITHDRAWAL FROM HEMODIALYSIS IN END-STAGE RENAL-FAILURE PATIENTS
    KATES, DM
    HAAS, L
    BRUNZELL, J
    SHERRARD, DJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 540 - 540
  • [50] Pharmacokinetics and Pharmacodynamics Of Pegloticase In Patients With End-Stage Renal Failure Receiving Hemodialysis
    Bleyer, Anthony J.
    Wright, David E.
    Glicklich, Alan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S497 - S498